A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India
Clinical trial NCT05219253 · COMPLETED
Trial details
- NCT number
- NCT05219253
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2022-10-11
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.